US Patent 10519251 Fabs-in-tandem immunoglobulin and uses thereof
Patent 10519251 was granted and assigned to EpimAb Biotherapeutics on December, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 24, 2014
Date of Patent
December 31, 2019
Patent Applicant
Patent Application Number
14732088
Patent Inventor Names
Chengbin Wu
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10519251 Fabs-in-tandem immunoglobulin and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
